Natural Polymers Collagen & Poly Β-Hydroxy Butyrate: Prepared By: Nishant Kumar Jain PE/2010/01

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 40

NATURAL POLYMERS

COLLAGEN & POLY β-HYDROXY BUTYRATE

PREPARED BY:
NISHANT KUMAR JAIN
PE/2010/01
CONTENTS:

INTRODUCTION
CLASSIFICATION
ADVANTAGES
DISADVANTAGES
APPLICATIONS
CASE STUDIES
WHY NATURAL POLYMERS ?
BIOCOMPATABLE
LESS TOXIC
BIODEGRADABLE
LESS STIMULATION OF IMMUNE RESPONSES
RECOGNITION BY CELLS
CLASSIFICATION:
CLASS EXAMPLES

PROTEINS COLLAGEN,SILK(FIBROIN),GELATIN,ELASTIN,A
CTIN,FIBRIN,ALBUMIN
POLYSACCHARIDES CELLULOSE,CHITOSAN,STARCH,GLYCOSAMIN
OGLYCAN,ALGINATE,HYALURONIC
ACID,CHONDROITIN
SULPHATE,AGAROSE,CYCLODEXTRIN,DEXTRA
N,CHITIN.
POLYNUCLEOTIDES DNA,RNA.

POLYHYDROXYALKANOATE POLY-β-HYDROXY BUTYRATE


S
GUMS ACACIA,AGAR,STERCULA ,XANTHAN
DISADVANTAGES:
IMMUNOGENIC
DURABILITY IS LESS
COMPLEX STRUCTURE
DECOMPOSE AT TEMPERATURE BELOW
MELTING POINT
VARIABILITY IN STRUCTURE & COMPOSITION
COLLAGEN:
27 DIFFERENT TYPES
MADEUP OF THE 20 DIFFERENT AMINO ACIDS
 TYPE 1(TROPOCOLLAGEN) IS MOST ABUNDANT
CHEMICAL STRUCTURE CONTAINS REPEATING
UNITS OF THE TYPE GLY-X-Y, WHERE X AND Y
MOSTLY ARE PROLINE AND HYDROXYPROLINE
PHYSICAL STRUCTURE IS A TRIPLE HELIX AS BASIC
UNITS WHICH AGGREGATE INTO FIBERS
BOVINE OR PORCINE SKIN/TENDON & GENETIC
ENGINEERING
THE COLLAGEN FROM OLD ANIMALS IS MORE
DIFFICULT TO EXTRACT FROM TISSUE
TYPES:
TYPE LOCATION COMMENT

I SKIN,TENDON,BONE WIDELY USED


FORMS FIBRILS

II CARTILAGE FORMS FIBRILS

III BLOOD VESSEL CONTAMINENT IN TYPE I


FORMS FIBRILS

IV EPITHELIAL TISSUE DOES NOT FORM FIBRILS


PROPERTIES:
PROPERTY VALUE

TENSILE STRENGHT 50-100 Mpa

TENSILE MODULUS 1000 Mpa

ELONGATION(%) 10

Tg 120°C

Tm 230°C

WATER ABSORPTION (%) >1

FLEXIBLE,BIO-COMPATABLE,BIO-DEGRADABLE,POROUS
TRUCTURE(SO USED AS SCAFFOLD FOR TISUE ENGINEERIN
SOLUBLE IN ACIDIC AQUEOUS SOLUTION.
MADE INTO TUBES,SHEETS,SPONGES,NANOFIBRES,POWDE
TC
PHYSICAL MODIFICATION:
HELIX-COIL TRANSISTION
 HELICAL MARKER BANDS
 ASSAY OF GELATIN
BANDING PATTERN
 LOST REVERSIBLY AT pH <4.25
 XRD,TEM
 COLLAGEN SPONGES
POROSITY
 PORT FOR ENTRY OF CELLS
 MORE SURFACE AREA FOR
INTERACTION
EX: MYOFIBROBLASTS-(COLLAGEN-GAG)COPOLYMER
CLOTTING FACTORS-COLLAGEN SPONGES
METHOD: FREEZING FOLLOWED BY SUBLIMATION
VARIOUS POROUS STRUCTURES
AVERAGE PORE SIZE DECREASES WITH DECREASE IN THE
TEMPERATURE OF THE FREEZING
PORE SIZE: COLLAGEN-GAG COPOLYMER
20-125µm FOR SKIN REGENARATION
<10µm FOR SCIATIC NERVE REGENERATION
CHEMICAL MODIFICATION:
COLLAGEN COLLAGENASE N- & C-TERMINAL
FRAGMENTS HELIX-COIL PHYSIOLOGICAL
TRANSISTION TEMPERATURE

GELATIN
REQUIRED FOR DEGRADATION
FOR IMMUNOGENICITY ENZYMES

OLIGOPEPTIDES
METHODS TO DECREASE DEGRADATION:

BY CROSSLINKING
 DEHYDRATIVE CROSSLINKING:
FORMATION OF THE INTERCHAIN PEPTIDE
BONDS.
CONFIRMED BY TITRATION
COMPOSITION REMAINS SAME
 CROSSLINKING AGENTS: USED IN IMPLANTS
DIALDEHYDES: GLUTARALDEHYDE
OTHERS INCLUDE FORMALDEHYDE,
CARBODIMIDE, HEXAMETHYLENE DI-
ISOCYANATE.
METHODS TO DECREASE
IMMUNOGENECITY

BY IDENTIFYING THE GROUPS THA T ARE


RECOGNISED AS FOREIGN BODIES IN HELICAL AS
WELL AS IN NON-HELICAL PORTION.

BY CROSSLINKING

TYPE-I IS VERY LESS IMMUNOGENIC SO USE FOR


THE VALVES
COPOLYMER: COLLAGEN-GAG
POROUS GRAFT COPOLYMER
WHY COPOLYMER ?
 DECREASE STIFFNESS & BRITTLENESS
 IMPROVING ADHESION TO WOUND
WHY GAG CHONDROITIN-6-PHOSPHATE?
(1) LOW ANTIGENICITY
(2) NON-TOXIC BREAKDOWN PRODUCTS
(3) DECREASE THE RATE OF COLLAGEN
BREAKDOWN AND
(4) ABILITY TO INCREASE THE STRENGTH
OF COLLAGENS WHILE MAKING THEM
MORE ELASTIC.
 METHOD
DERMIS REGENERATIVE TEMPLATE:2WKS
NERVE REGENERATIVE TEMPLATE: 6WKS
MECHANISM: SYNCHRONOUS ISOMORPHOUS
REPLACEMENT
IN DRUG DELIVERY:
BUCCAL MUCOSAL ADHESIVE FILMS-TETRACYCLIN
BUCCAL MUCOSAL ADHESIVE GELS-CHLORHEXIDINE
DRUG (PILOCARPINE) IS INCORPORATED INTO THE
FILMS AND ITS RELEASE IS DELAYED. COLLAGEN IS
COMPLETELY HYDROLYZED AFTER 5 TO 6 HOURS IN
THE EYE, LEAVING NO RESIDUAL.
LOCALIZED DRUG DELIVERY OF THE LOW MOLECULAR
WEIGHT DRUGS INCLUDING
ANTIBIOTICS.EX:GENTAMYCIN-SULMYAN
IMPLANT,COLLATAMP-G
PROLONGED RELEASE(SEPTOCOLL)-
TWO SALTS OF DIFFERENT SOLUBILITIES
GENTAMYCIN USED
IN GENE & PROTEIN DELIVERY USING
TISSUE ENGINEERING:
CASE STUDY:
SUCCINYLATED/METHYLATED COLLAGEN AS A
EFFECTIVE DRUG CARRIER
IMPROVED PATIENT COMPLIANCE
PROLONGED RELEASE OF DRUG
PILOCARPINE,DEXAMETHAZONE,GENTAMYCIN,TE
TRACYCLIN,KANAMYCIN,NEOMYCIN,
POLY-β-HYDROXY
BUTYRATE(PHB):

DISCOVERED IN Bacillus megaterium IN 1920 & THEN


IN OTHER BACTERIA’S ALSO.
BIOTECHNOLOGICALLLY PRODUCED FROM
Psuedomonas olevorans & Acaligenes eutrophus.
PHB & PHV ARE THE INTRACELLULAR STORAGE
POLYMERS
CRYSTALLINE ISOTACTIC POLYMER
PROPERTIES:
SOLUBLE IN WIDE RANGE OF SOLVENTS
DEGRADED BY SOIL BACTERIA
STABLE AT PHYSIOLOGICAL CONDITIONS
REQUIRES SEVERAL YEARS FOR RESORPTION IN
VIVO.(ORTHOPEDIAC APPLICATION)
PIEZOELECTRICITY (IN TISSUE
ENGINEERING,DRUG DELIVERY & IN
ORTHOPEDIAC APPLICATION)
UNDERGOES SURFACE EROSION
COPOLYMER MP IS LESS
MADE INTO FILMS,SHEETS,SPHERES,FIBRES ETC
PROPERTY VALUE

TENSILE STRENGHT 40 Mpa

TENSILE MODULUS 3500 Mpa

ELONGATION(%) 5

Tg 4°C

Tm 179°C

DENSITY 1.26gm/cm³, 1.18gm/cm³

MOLECULAR WEIGHT 10,000-30,00,000 Da


METHOD OF PREPARATION:
FROM BACTERIA
BY CHEMICAL REACTION: RING OPENING
POLYMERISATION OF β-BUTYROLACTONE
ADVANTAGES:

BIOCOMPATABLE
BIODEGRADABLE
PRODUCED FROM RENEWABLE RESOURCE
NON TOXIC

DISADVANTAGES:
VERY LOW DEGRADATION RATE(6MONTHS)
PYROGENS
HIGH STIFFNESS
BRITTLENESS
COMMERCIALLY AVAILABLE
TYPES:
HOMOPOLYMER: CRYSTALLINE & BRITTLE
 BIOPOL GO4

COPOLYMER: WITH HYDROXY VALERIC ACID(HVA)


 LESS CRYSTALLINE
 MORE FLEXIBLE
 EASILY PROCESSABLE MATERIAL
 DEGRADE FASTER
 DISADV: HIGH COST
 PHB+3%3-HVA- BIPOL
 PHB+24%-HVA-BIOPOL PO5
INCREASING DEGRADATION
RATE:
BY ϒ- RADIATIONS
BY COPOLYMER WITH PHV
USING HYDROPHILIC POLYMERS

REMOVAL OF PYROGENS:
OXIDIZING AGENTS. EX: HYDROGEN PEROXIDE OR
BENZOYL PEROXIDE
<20 ENDOTOXIN UNITS/GRAM OF PHB
OTHER MODIFICATIONS:
PHB+PLASTICIZERS(CAPROL)-IMPROVE DUCTILITY
PHB-CO-PHV COPOLYMER TREATED WITH ALLYL
ALCOHOL GAS PLASMA-INCREASED WETTABILITY
PHB+SALT BLEND-INCREASED POROSITY (TRIPLE
LEAFLET HEART VALVE)
60% POLYCAPROLACTAM+PHB-IMPROVED
MECHANICAL PROPERTIES & DECREASED O 2
PERMEABILITY
APPLICATIONS:
IN PACKAGING FILMS
SIMILAR APPLICATIONS AS CONVENTIONAL
COMMODITY PLASTICS INCLUDE THE DISPOSABLE
ITEMS, SUCH AS RAZORS, UTENSILS, DIAPERS,
COSMETIC CONTAINERS—SHAMPOO BOTTLES AND
CUPS.
AS STEREO REGULAR COMPOUNDS
USED AS BIODEGRADABLE CARRIERS FOR LONG-
TERM DELIVERY OF DRUGS
THEY ARE ALSO USED AS OSTEOSYNTHETIC
MATERIALS IN THE STIMULATION OF BONE GROWTH
OWING TO THEIR PIEZOELECTRIC PROPERTIES, IN
BONE PLATES, SURGICAL SUTURES AND BLOOD
VESSEL REPLACEMENTS
APLLICATIONS IN MEDICINE:

TETRACYCLIN,METRONIDAZOLE
LHRH IMPLANT
CRITERIA’S FOR A SUCCESSFUL SCAFFOLD:

WILLIAMS AND PEOPLES


(1) BIOCOMPATIBILITY,
(2) SUPPORT CELL GROWTH AND CELL
ADHESION
(3) GUIDE & ORGANIZE THE CELLS
(4) ALLOW INGROWTH OF CELLS AND PASSAGE
OF NUTRIENTS AND WASTE PRODUCTS
(5) BIODEGRADABLE WITHOUT FORMATION OF
TOXIC COMPOUNDS.
EVALUATION OF POLYHYDROXYBUTYRATE
AND OF POLYHYDROXYBUTYRATE
REINFORCED WITH HA:
HYDROXYAPATITE (HA)/PHB, HA/GLASS/PHB
COMPOSITES FOR BONE TISSUE
ENGINEERING:
 THE FIRST, A HA/ PHB COMPOSITE SHOWED AN INCREASE IN
INTERFACIAL SHEAR STRENGTH (ISS) UP TO 8 WEEKS.
 THE SECOND COMPOSITE WAS AN HA/GLASS/PHB (HGP) COMPOSITE
AND THIS GAVE LOWER VALUES FOR THE ISS ATTRIBUTED TO ION
RELEASE FROM THE GLASS CAUSING A SOFT TISSUE REACTION AT
THE INTERFACE.
 THE THIRD COMPOSITE WAS A CARBON FIBER REINFORCED
POLYSULFONE (CFRP) AND THIS SHOWED HIGH INTERFACIAL
SHEAR STRENGTH VALUES.
 HISTOLOGY, WHICH SHOWED ENHANCED ENDOSTEAL BONE
GROWTH FOR THE HA/PHB BUT FOR THE HGP, NO PERIOSTEAL OR
ENDOSTEAL ACTIVITY WAS DETECTED.
 IT WAS CONCLUDED THAT THE HIGH ISS VALUES FOR THE CARBON
FIBER CONTROL WERE DUE TO SURFACE MORPHOLOGY ALLOWING
DEEP INGROWTH OF SOFT TISSUE AND THIS WAS CONFIRMED BY
SEM
EFFECT OF CLAY ORGANOMODIFIERS ON
DEGRADATION OF POLYHYDROXYALKANOATES:
EFFECT OF PHB BLENDING WITH OTHER
POLYMERS ON BIOCOMPATIBILITY:
CHENG ET AL. PREPARED A SERIES OF PHB AND
POLYETHYLENE GLYCOL (PEG) BLEND MATERIALS
WITH DIFFERENT RATIOS RANGING FROM 80:20
(WT%) TO 20:80 (WT%) BY SOLUTION BLEND.
THE BLOOD-COMPATIBILITY WAS EVALUATED BY
MEANS OF PLATELET CLOTTING TIME TEST AND
EXPLORING ITS MORPHOLOGICAL CHANGES.
THE RESULTS SHOWED THAT PEG PLAYED AN
IMPORTANT ROLE IN RESISTING PLATELET
ADHESION
CONTROLLED DEGRADATION OF
POLYHYDROXYBUTYRATE VIA ALCOHOLYSIS WITH
ETHYLENE GLYCOL OR GLYCEROL
1) Patrícia B. Malafaya,Gabriela A. Silva, Rui L. Reis Natural–origin polymers as
carriers and scaffolds for biomolecules and cell delivery in tissue engineering
Applications,Advanced Drug Delivery Reviews 59 (2007) 207–233
2) Andrew W. Lloyd, Richard G.A. Faragher, Stephen P. Denyer , Ocular
biomaterials and Implants, Biomaterials 22 (2001) 769-785
3) Nazila Salamat-Miller, Montakarn Chittchang, Thomas P. Johnston, The use of
mucoadhesive polymers in buccal drug delivery, Advanced Drug Delivery
Reviews 57 (2005) 1666– 1691
4) Zbigniew Ruszczaka, Wolfgang Friess, Collagen as a carrier for on-site delivery of
antibacterial Drugs, Advanced Drug Delivery Reviews 55 (2003) 1679– 1698
5) Wolfgang Friess, Collagen - biomaterial for drug delivery, European Journal of
Pharmaceutics and Biopharmaceutics 45 (1998) 113–136
6) Jiyoung M. Dang, Kam W. Leong, Natural polymers for gene delivery and tissue
engineering,
Advanced Drug Delivery Reviews 58 (2006) 487– 499
7) Shilpi Khanna, Ashok K. Srivastava, Recent advances in microbial
polyhydroxyalkanoates, Process ,Biochemistry 40 (2005) 607–619
8) Manfred Zinna, Bernard Witholtb, Thomas Egli, Occurrence, synthesis and
medical application of Bacterial polyhydroxyalkanoate, Advanced Drug Delivery
9) Guo-Qiang Chen, Qiong Wua, The application of polyhydroxyalkanoates as
tissue engineering materials,Biomaterials 26 (2005) 6565–6578
10) J. Mergaert,C. Anderson, A. Wouters, j. Swings and K. Kersters,
Biodegradation of polyhydroxyalkanoates, FEMS Microbiology Reviews 103
(1992) 317-322
11) Perrine Bordes, Elodie Hablot, Eric Pollet, Luc Ave´rous, Effect of clay
organomodifiers on degradation of polyhydroxyalkanoates, Polymer Degradation
and Stability 94 (2009) 789–796
12) Colin W. Pouton, Saghir Akhtarb, Biosynthetic polyhydroxyalkanoates and
their potential in drug Delivery , Advanced Drug Delivery Reviews 18 (1996) 133-
162
13) C. Doyle, E.T. Tanner and W. Bonfield, In vitro and in vivo evaluation of
polyhydroxy-butyrate and of polyhydroxybutyrate reinforced with hydroxyapatite.
biomaterials 1997, vol-72, November 841-847
14) D.M. Zhanga, F.Z. Cuia,U, Z.S. Luoa, Y.B. Lina, K. Zhaob, G.Q. Chenb,
Wettability improvement of bacterial polyhydroxyalkanoates via ion implantation,
Surface and Coatings Technology 131 (2000). 350-354
15)Lakshmi S. Naira, Cato T. Laurencin, Biodegradable polymers as biomaterials,
Prog. Polym. Sci. 32 (2007) 762–798
16)Biomaterial science-An introduction to biomaterials by B.D.Ratner,2 nd
edition,127-136
ANY
E RI E
QU
S?

You might also like